Edgewise announces completion of EDG-7500 CIRRUS-HCM phase 2 parts B & C and favourable interim safety results from the ongoing part D study in hypertrophic cardiomyopathy ...

Discover why Edgewise Therapeutics, Inc. is rated Buy amid strong trial data, unique HCM treatment, and major 2026 catalysts. Click for this EWTX update.

Hackensack Meridian JFK’s chief of cardiology explains how alcohol, salty foods, and holiday excess can lead to dangerous ...

Cardiovascular disease remains a leading global cause of death, and we break down its pathology, risk factors, and the ...

A new study suggests the vagus nerve may be one of the heart’s most important defenders against aging. Researchers found that ...

Scientists have uncovered new evidence showing how type 2 diabetes directly reshapes the human heart, altering both its energy production and physical structure.